Incorporating genomics into breast cancer management [ 2019 - ]

Research Grant

Researchers: Dr Lironne Wein (Principal investigator)

Brief description This study will investigate use of genomic sequencing in advanced and early breast cancer. We will characterise genetic characteristics of patients who benefit from two different therapies in the metastatic setting. We will use circulating tumour DNA analysis to monitor for and genetically characterise minimal residual disease (MRD) in patients apparently cured by initial therapy. This will thus identify potential therapeutic targets for preventing MRD progressing to metastatic disease.

Funding Amount $126,437.00

Funding Scheme Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship